Explore recent insider activity at Aquestive Therapeutics (NYSE:AQST), ownership trends, and what they may indicate about the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Aquestive Therapeutics (AQST) one of those stocks right now? By taking a look at ...

Aquestive Therapeutics (AQST) reported $11.87 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 10.2%. EPS of -$0.19 for the same period compares to ...

For the quarter ended December 2025, Aquestive Therapeutics (AQST Quick Quote AQST - Free Report) reported revenue of $13.02 million, up 9.7% over the same period last year. EPS came in at -$0.26, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Aquestive Therapeutics (AQST Quick Quote AQST - Free Report) one of those stocks ...

Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut butter sandwich demonstrates consistent Tmax of 12 minutes Study results for swallowing ...

Aquestive Therapeutics (NASDAQ:AQST) is preparing to release its quarterly earnings on Wednesday, 2026-03-04. Here's a brief overview of what investors should keep in mind before the announcement.

It has been over six months since my previous Aquestive Therapeutics (AQST) article, where I discussed Anaphylm's potential approval and some of the possible catalysts along the way to their FDA PDUFA ...